Skip to content

Marketed Contact Lens Real World Through Focus Curve

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02679976
Enrollment
30
Registered
2016-02-11
Start date
2015-07-31
Completion date
2015-08-31
Last updated
2016-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Acuity

Brief summary

This is a single-visit prospective study to establish a real world Marketed Contact Lens 'Through Focus Curve' (TFC) measurement by comparing the consistency of vision between myopes and hyperopes. 33 subjects will be enrolled (at least 15 myopes and 15 hyperopes), who are 40 years of age or older, for a 1-visit, 4-hour study for measurements to be taken.

Interventions

DEVICEetafilcon A

Marketed Multifocal Contact Lens

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form. * The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol. * The subject must be ≥40 years of age. * The subjects' optimal vertexed spherical equivalent distance correction must be between -6.00 Diopters (D) and +4.00 D in each eye. * The subject's refractive cylinder must be ≤ -0.75 D in each eye. * The subject's ADD power must be in the range of +0.75 to +2.50 D in each eye. * The subject must have best corrected visual acuity of 20/25 or better for each eye. * The subject can be either a new contact lens wearer or an existing soft contact lens wearer.

Exclusion criteria

* Currently pregnant or lactating. * Any ocular or systemic allergies that contraindicate contact lens wear. * Any ocular or systemic disease, autoimmune disease, or use of medication that contraindicates contact lens wear. * Any ocular abnormality that may interfere with contact lens wear. * Use of any ocular medication, with the exception of rewetting drops. * Any previous intraocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.) * Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, and conjunctival injection) which may contraindicate contact lens wear. * History of herpetic keratitis. * Any ocular infection or inflammation. * Any corneal distortion or irregular cornea. * History of binocular vision abnormality or strabismus. * Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV). * History of diabetes. * Participant in unrelated research involving test product within 30 days before planned study visit.

Design outcomes

Primary

MeasureTime frameDescription
Distance Binocular LogMAR Visual Acuity4 Hr. Post FittingDistance Binocular LogMAR Visual Acuity was measured at 4m for Low luminance ( 2.5 CD/M\^2 ), Medium luminance ( 50 CD/M\^2 ) and High luminance ( 250 CD/M\^2 )
Near Binocular LogMAR Visual Acuity4 Hr. Post FittingNear Binocular LogMAR Visual Acuity was measured at 40cm for Low luminance ( 2.5 CD/M\^2 ), Medium luminance ( 50 CD/M\^2 ) and High luminance ( 250 CD/M\^2 )
Intermediate Binocular LogMAR Visual Acuity4 Hr. Post Fittingintermediate Binocular LogMAR Visual Acuity was measured at 67cm for Low luminance ( 2.5 CD/M\^2 ), Medium luminance ( 50 CD/M\^2 ) and High luminance ( 250 CD/M\^2 )

Countries

United Kingdom

Participant flow

Pre-assignment details

A total of 30 subjects were enrolled into this study. Subjects were stratified as either Hyperope or Myopes using a 1:1 allocation. All enrolled subjects completed the study.

Participants by arm

ArmCount
Etafilcon A (Multi-focal)
All subjects wore etafilcon A(multi-focal) during the study. Subjects were stratified as either Myopes or Hyperopes based on their sphere power.
30
Total30

Baseline characteristics

CharacteristicEtafilcon A (Multi-focal)
Age, Continuous51.7 years
STANDARD_DEVIATION 7.37
Race/Ethnicity, Customized
American Indian Or Alaska Native
0 participants
Race/Ethnicity, Customized
Asian
2 participants
Race/Ethnicity, Customized
Black or African American
16 participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 participants
Race/Ethnicity, Customized
Other
2 participants
Race/Ethnicity, Customized
White
10 participants
Region of Enrollment
United Kingdom
30 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Distance Binocular LogMAR Visual Acuity

Distance Binocular LogMAR Visual Acuity was measured at 4m for Low luminance ( 2.5 CD/M\^2 ), Medium luminance ( 50 CD/M\^2 ) and High luminance ( 250 CD/M\^2 )

Time frame: 4 Hr. Post Fitting

Population: The analysis population includes all subjects that completed the study without a major protocol deviation.

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon A (Multi-focal)- HyperopesDistance Binocular LogMAR Visual AcuityLow Luminance; N=16, N=14-1.072 -10*LogMARStandard Deviation 0.8748
Etafilcon A (Multi-focal)- HyperopesDistance Binocular LogMAR Visual AcuityMedium Luminance; N=16, N=140.9017 -10*LogMARStandard Deviation 0.45
Etafilcon A (Multi-focal)- HyperopesDistance Binocular LogMAR Visual AcuityHigh Luminance; N=16, N=141.488 -10*LogMARStandard Deviation 0.696
Etafilcon A (Multi-focal)- MyopesDistance Binocular LogMAR Visual AcuityLow Luminance; N=16, N=14-0.904 -10*LogMARStandard Deviation 1.1423
Etafilcon A (Multi-focal)- MyopesDistance Binocular LogMAR Visual AcuityMedium Luminance; N=16, N=140.557 -10*LogMARStandard Deviation 0.9465
Etafilcon A (Multi-focal)- MyopesDistance Binocular LogMAR Visual AcuityHigh Luminance; N=16, N=141.471 -10*LogMARStandard Deviation 1.65
Primary

Intermediate Binocular LogMAR Visual Acuity

intermediate Binocular LogMAR Visual Acuity was measured at 67cm for Low luminance ( 2.5 CD/M\^2 ), Medium luminance ( 50 CD/M\^2 ) and High luminance ( 250 CD/M\^2 )

Time frame: 4 Hr. Post Fitting

Population: The analysis population includes all subjects that completed the study without a major protocol deviation.

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon A (Multi-focal)- HyperopesIntermediate Binocular LogMAR Visual AcuityLow Luminance; N=16, N=14-1.544 -10*LogMARStandard Deviation 1.0355
Etafilcon A (Multi-focal)- HyperopesIntermediate Binocular LogMAR Visual AcuityMedium Luminance; N=16, N=14-0.075 -10*LogMARStandard Deviation 0.8367
Etafilcon A (Multi-focal)- HyperopesIntermediate Binocular LogMAR Visual AcuityHigh Luminance; N=16, N=141.056 -10*LogMARStandard Deviation 0.7616
Etafilcon A (Multi-focal)- MyopesIntermediate Binocular LogMAR Visual AcuityLow Luminance; N=16, N=14-1.318 -10*LogMARStandard Deviation 1.477
Etafilcon A (Multi-focal)- MyopesIntermediate Binocular LogMAR Visual AcuityMedium Luminance; N=16, N=140.043 -10*LogMARStandard Deviation 1.141
Etafilcon A (Multi-focal)- MyopesIntermediate Binocular LogMAR Visual AcuityHigh Luminance; N=16, N=141.157 -10*LogMARStandard Deviation 0.7037
Primary

Near Binocular LogMAR Visual Acuity

Near Binocular LogMAR Visual Acuity was measured at 40cm for Low luminance ( 2.5 CD/M\^2 ), Medium luminance ( 50 CD/M\^2 ) and High luminance ( 250 CD/M\^2 )

Time frame: 4 Hr. Post Fitting

Population: The analysis population includes all subjects that completed the study without a major protocol deviation.

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon A (Multi-focal)- HyperopesNear Binocular LogMAR Visual AcuityHigh Luminance; N=16, N=140.828 -10*LogMARStandard Deviation 0.991
Etafilcon A (Multi-focal)- HyperopesNear Binocular LogMAR Visual AcuityLow Luminance; N=16, N=14-2.278 -10*LogMARStandard Deviation 1.6989
Etafilcon A (Multi-focal)- HyperopesNear Binocular LogMAR Visual AcuityMedium Luminance; N=16, N=14-0.591 -10*LogMARStandard Deviation 1.4003
Etafilcon A (Multi-focal)- MyopesNear Binocular LogMAR Visual AcuityLow Luminance; N=16, N=14-2.261 -10*LogMARStandard Deviation 1.703
Etafilcon A (Multi-focal)- MyopesNear Binocular LogMAR Visual AcuityMedium Luminance; N=16, N=14-0.650 -10*LogMARStandard Deviation 1.5274
Etafilcon A (Multi-focal)- MyopesNear Binocular LogMAR Visual AcuityHigh Luminance; N=16, N=140.786 -10*LogMARStandard Deviation 1.048

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026